Organization Profile

You just read:

Health Canada Approves Genzyme's AUBAGIO® (teriflunomide), a Once-Daily, Oral Treatment for Relapsing Remitting Multiple Sclerosis

News provided by

Genzyme

Nov 20, 2013, 08:00 ET